Tak Mao Chan Selected Research

Complement C3 (C3 Complement)

1/2021	Serum syndecan-1, hyaluronan and thrombomodulin levels in patients with lupus nephritis.
1/2017	Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tak Mao Chan Research Topics

Disease

42	Lupus Nephritis 01/2023 - 04/2005
23	Infections 01/2022 - 01/2002
20	Proteinuria 06/2023 - 12/2007
19	Inflammation (Inflammations) 07/2022 - 05/2002
18	Fibrosis (Cirrhosis) 01/2022 - 11/2006
15	Peritonitis 02/2020 - 11/2005
12	Neoplasms (Cancer) 09/2023 - 03/2006
10	Chronic Renal Insufficiency 03/2021 - 02/2003
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 04/2005
9	Renal Insufficiency (Renal Failure) 01/2023 - 02/2003
9	Nephritis 01/2022 - 09/2008
8	IGA Glomerulonephritis (IGA Nephropathy) 11/2023 - 10/2002
8	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 09/2008
7	Hepatitis B 09/2014 - 09/2002
6	Acute Kidney Injury (Acute Renal Failure) 06/2023 - 07/2004
6	Kidney Diseases (Kidney Disease) 01/2022 - 01/2018
5	Albuminuria 01/2023 - 09/2008
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 12/2012
4	COVID-19 04/2024 - 12/2020
4	Peritoneal Fibrosis 02/2020 - 06/2007
4	Chronic Hepatitis B 10/2019 - 01/2002
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2014 - 10/2002
3	Atrophy 01/2022 - 01/2015
3	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2022 - 12/2007
3	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2014 - 12/2007
3	Disease Progression 11/2003 - 10/2002
2	Sepsis (Septicemia) 07/2022 - 11/2017
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2021 - 01/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2021 - 01/2012
2	Anemia 03/2021 - 01/2020
2	Human Influenza (Influenza) 01/2021 - 01/2016
2	Cognitive Dysfunction 10/2019 - 01/2019
2	Virus Diseases (Viral Diseases) 01/2019 - 02/2007
2	Neoplasm Metastasis (Metastasis) 01/2018 - 07/2007
2	Hepatitis 01/2016 - 02/2005

Drug/Important Bio-Agent (IBA)

13	anti-dsDNA autoantibodyIBA 01/2023 - 09/2008
13	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2022 - 12/2007
12	CreatinineIBA 01/2023 - 02/2003
9	CytokinesIBA 12/2021 - 09/2002
8	Immunoglobulin G (IgG)IBA 01/2019 - 04/2004
7	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 04/2005
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
7	Sirolimus (Rapamycin)FDA Link 01/2022 - 10/2006
6	Fibronectins (Fibronectin)IBA 01/2022 - 07/2009
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 11/2005
6	Hyaluronic Acid (Hyaluronan)IBA 06/2021 - 01/2011
6	Lamivudine (Epivir)FDA Link 10/2019 - 01/2002
6	AutoantibodiesIBA 12/2017 - 02/2010
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2015
5	Calcineurin InhibitorsIBA 03/2022 - 01/2015
5	Prednisolone (Predate)FDA LinkGeneric 03/2022 - 12/2007
5	Tacrolimus (Prograf)FDA LinkGeneric 03/2022 - 11/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2009
5	SteroidsIBA 01/2021 - 12/2007
5	Antigen-Antibody Complex (Immune Complex)IBA 12/2017 - 01/2013
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015 - 01/2009
4	C-Reactive ProteinIBA 01/2023 - 05/2007
4	Methylprednisolone FDA LinkGeneric 01/2022 - 03/2007
4	Antinuclear AntibodiesIBA 01/2021 - 11/2005
4	AntibodiesIBA 01/2021 - 02/2008
4	AntigensIBA 01/2020 - 12/2012
4	entecavir FDA Link 10/2019 - 03/2010
3	CollagenIBA 01/2022 - 01/2015
3	MicroRNAs (MicroRNA)IBA 10/2021 - 04/2017
3	Hemoglobins (Hemoglobin)IBA 03/2021 - 01/2019
3	Dialysis SolutionsIBA 02/2020 - 12/2012
3	Immunosuppressive Agents (Immunosuppressants)IBA 12/2018 - 07/2012
3	Inflammation MediatorsIBA 04/2017 - 01/2012
3	NucleosidesIBA 05/2016 - 08/2010
3	AdiponectinIBA 03/2015 - 05/2007
3	adefovirIBA 01/2014 - 03/2010
3	GlycosaminoglycansIBA 01/2013 - 06/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2012 - 09/2007
2	ElectrolytesIBA 02/2024 - 10/2019
2	LigandsIBA 11/2023 - 11/2023
2	GlucocorticoidsIBA 01/2022 - 03/2013
2	Indicators and Reagents (Reagents)IBA 01/2022 - 07/2008
2	Complement System Proteins (Complement)IBA 01/2022 - 11/2005
2	Immunoglobulins (Immunoglobulin)IBA 12/2021 - 04/2017
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2021 - 10/2002
2	Syndecan-1 (Syndecan 1)IBA 06/2021 - 01/2021
2	ThrombomodulinIBA 06/2021 - 01/2021
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2021 - 03/2015
2	Complement C3 (C3 Complement)IBA 01/2021 - 01/2017
2	Antiviral Agents (Antivirals)IBA 12/2020 - 08/2010
2	DecorinIBA 02/2020 - 03/2015
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019 - 01/2017
2	Annexin A2 (Annexin II)IBA 04/2017 - 11/2010
2	InterferonsIBA 01/2017 - 02/2007
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 03/2015

Therapy/Procedure

23	Therapeutics 03/2022 - 01/2002
22	Peritoneal Dialysis 09/2021 - 04/2003
7	Kidney Transplantation 01/2021 - 01/2002
6	Continuous Ambulatory Peritoneal Dialysis (CAPD) 09/2007 - 04/2003
5	Transplantation 01/2021 - 11/2003
3	Renal Dialysis (Hemodialysis) 11/2023 - 01/2016
3	Catheters 01/2012 - 01/2010
2	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2024 - 01/2019
2	Palliative Care (Palliative Therapy) 09/2023 - 01/2018
2	Antibiotic Prophylaxis 01/2022 - 09/2007